Study to assess the safety and Immunogenicity of monovalent mRNA NA vaccine in adult participants 18 years of age and older

Trial Identifier:	FBP00012
Sponsor:	Sanofi Pasteur, a Sanofi Company
Start Date:	June 2022
Primary Completion Date:	January 2024
Study Completion Date:	January 2024
Condition:	Influenza Immunisation; Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United States	United States

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.